In a move that reeks of bureaucratic overreach and questionable priorities, the Food and Drug Administration (FDA) has rubber-stamped Wildtype Inc.’s lab-grown salmon, the first of its kind approved for human consumption in the U.S.
Derived from mesenchymal lineage cells and mixed with plant-based goo to mimic sushi-grade saku cuts, this franken-fish is being hailed as a “sustainable” solution to overfishing.
Meanwhile, HHS Secretary Robert F. Kennedy Jr. is shaking up the public health establishment, firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) in a bid to root out conflicts of interest and restore trust in vaccine science.
The contrast couldn’t be starker: one agency pushes untested biotech food on the public, while another tries to clean house of industry-aligned insiders. Welcome to the brave new world of “Gold Standards.”
Wildtype’s cultured salmon, approved in June 2025 under FDA consultation CCC 000005, is grown in bioreactors over four to six weeks, sidestepping nature’s blueprint for a lab-bred alternative.
Hellbound and Down 